Abbott Cephea mitral valve disease registry
Part of Digestive system, Heart & circulation clinical trials.
This study tracks people with mitral valve disease who receive the Cephea valve through a tube in an artery rather than open-heart surgery. It looks at how well the valve works over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mitral valve disease that causes backward blood flow (regurgitation) or narrowing (stenosis).
- You have symptoms like shortness of breath or fatigue that affect daily activities (NYHA class II, III, or IV).
- Your heart team believes a catheter-based valve replacement is a better option than surgery or a repair clip.
- You are 18 years or older.
- You agree to follow the study rules and give your written permission to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device called the Cephea valve, which is placed through a small tube (catheter) to treat severe leaking or narrowing of the mitral valve. It may be an option for people who are not good candidates for open-heart surgery.
This study tests a new device called the MRace implant that is designed to repair a leaky mitral valve without open-heart surgery. It may help people with severe leakage who are at high risk for traditional surgery.
This study keeps a registry of adults who have a mitral valve problem and are being evaluated for a catheter-based mitral valve replacement. It helps doctors understand what treatments are used and how patients do.
This study is a registry (a way to track real-world outcomes) for people with mitral valve disease who receive a mitral valve procedure. It helps doctors understand how well these procedures work and what complications happen in patients like you.
This trial focuses on people with severe mitral valve narrowing or leaking who still have symptoms even after the best usual medications. It may help find better care and measure health outcomes when surgery is judged too risky or not suitable.
This study tests a new catheter-based system to treat severe mitral valve leaking when open-heart surgery is considered high risk. It may help improve blood flow and symptoms by repairing the valve without open surgery, using ultrasound guidance and follow-up visits to track safety and results.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.